<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:e678c0d8-948e-438c-896f-28ba36a68c64,g:29efd991-2323-4e80-b11c-f37be38816e6,d:fc087ab699b14593b3ee3c663a0e640a--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ebs-20210520</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ic48162d9263a4ff69d74e39dc4f3908f_D20200113-20200113" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV80L2ZyYWc6ODUyYmNhZGZhYzA2NDZhNmEyZmRlMDc0MjViZjA1NTIvdGFibGU6NjU2N2I1NzM2ZjQyNDgyOThlZDAwZGQzMjYwZjUxMDUvdGFibGVyYW5nZTo2NTY3YjU3MzZmNDI0ODI5OGVkMDBkZDMyNjBmNTEwNV8yLTEtMS0xLTA_facffe42-671f-4bda-8125-1fc037293fc5">0001367644</ix:nonNumeric><ix:nonNumeric contextRef="ic48162d9263a4ff69d74e39dc4f3908f_D20200113-20200113" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV80L2ZyYWc6ODUyYmNhZGZhYzA2NDZhNmEyZmRlMDc0MjViZjA1NTIvdGFibGU6NjU2N2I1NzM2ZjQyNDgyOThlZDAwZGQzMjYwZjUxMDUvdGFibGVyYW5nZTo2NTY3YjU3MzZmNDI0ODI5OGVkMDBkZDMyNjBmNTEwNV81LTEtMS0xLTA_79f74648-510b-42f7-b2f3-9a6e18e8bcce">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ebs-20210520.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-20</xbrli:startDate><xbrli:endDate>2021-05-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic48162d9263a4ff69d74e39dc4f3908f_D20200113-20200113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367644</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-13</xbrli:startDate><xbrli:endDate>2020-01-13</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ifc087ab699b14593b3ee3c663a0e640a_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGV4dHJlZ2lvbjphZmM5MjZhMmY5MDM0NTE1YmQ2NGI0ZTRlZTJhMzE0MF8yMzQ1_acb2ecd3-a974-4757-b99e-c9b2638eca74">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGV4dHJlZ2lvbjphZmM5MjZhMmY5MDM0NTE1YmQ2NGI0ZTRlZTJhMzE0MF8yMzM0_45719c57-dee7-432d-94a0-e32ff6310f66"><ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGV4dHJlZ2lvbjphZmM5MjZhMmY5MDM0NTE1YmQ2NGI0ZTRlZTJhMzE0MF8yMzM0_d3240e1a-98a0-464d-99da-b9e6a2a189cc">May 20, 2021</ix:nonNumeric></ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGV4dHJlZ2lvbjphZmM5MjZhMmY5MDM0NTE1YmQ2NGI0ZTRlZTJhMzE0MF8yMzQy_e80512ea-3170-4dff-9295-266e1ad26250">EMERGENT BIOSOLUTIONS INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:30.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGFibGU6NzVhOWUyN2MyMzIzNGQ3OWIzZjBkZTY0YWE0YzZhZjkvdGFibGVyYW5nZTo3NWE5ZTI3YzIzMjM0ZDc5YjNmMGRlNjRhYTRjNmFmOV8wLTAtMS0xLTA_6e07a8ae-5251-4ae1-b37a-d3f6dee4ecf8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGFibGU6NzVhOWUyN2MyMzIzNGQ3OWIzZjBkZTY0YWE0YzZhZjkvdGFibGVyYW5nZTo3NWE5ZTI3YzIzMjM0ZDc5YjNmMGRlNjRhYTRjNmFmOV8wLTItMS0xLTA_c3f33583-d188-434f-91bf-ba4bd10aa59b">001-33137</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGFibGU6NzVhOWUyN2MyMzIzNGQ3OWIzZjBkZTY0YWE0YzZhZjkvdGFibGVyYW5nZTo3NWE5ZTI3YzIzMjM0ZDc5YjNmMGRlNjRhYTRjNmFmOV8wLTQtMS0xLTA_ca33b716-7acc-4f30-a788-060ae75c6b49">14-1902018</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(IRS Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGV4dHJlZ2lvbjphZmM5MjZhMmY5MDM0NTE1YmQ2NGI0ZTRlZTJhMzE0MF8yMzQz_1128dfb1-badc-4b0c-a40e-df287af845ac">400 Professional Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGV4dHJlZ2lvbjphZmM5MjZhMmY5MDM0NTE1YmQ2NGI0ZTRlZTJhMzE0MF8yMzM1_e98be0e7-6de0-491d-9b9c-d856c0994c99">Suite 400</ix:nonNumeric>,</span></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGV4dHJlZ2lvbjphZmM5MjZhMmY5MDM0NTE1YmQ2NGI0ZTRlZTJhMzE0MF8yMzM2_b484c1c6-edaa-4eef-bed3-597ecb89a77c">Gaithersburg</ix:nonNumeric>, <ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGV4dHJlZ2lvbjphZmM5MjZhMmY5MDM0NTE1YmQ2NGI0ZTRlZTJhMzE0MF8yMzMz_041bad56-21f4-4dc0-87c4-c30465762472">Maryland</ix:nonNumeric> <ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGV4dHJlZ2lvbjphZmM5MjZhMmY5MDM0NTE1YmQ2NGI0ZTRlZTJhMzE0MF8yMzM3_df3e8bb8-ca50-449f-93fb-dfac92e1e406">20879</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGV4dHJlZ2lvbjphZmM5MjZhMmY5MDM0NTE1YmQ2NGI0ZTRlZTJhMzE0MF8yMzM4_3f81ce28-2973-4f4e-948e-b16d2bd96cdf">240</ix:nonNumeric>) <ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGV4dHJlZ2lvbjphZmM5MjZhMmY5MDM0NTE1YmQ2NGI0ZTRlZTJhMzE0MF8yMzQ3_2fbf5b00-308e-4761-81bd-22d1c34a2332">631-3200</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General Instruction A.2. below):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGV4dHJlZ2lvbjphZmM5MjZhMmY5MDM0NTE1YmQ2NGI0ZTRlZTJhMzE0MF8yMzQ2_fee72be8-805d-45a3-98da-6c16e3e6d040">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160; Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)&#160;</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGV4dHJlZ2lvbjphZmM5MjZhMmY5MDM0NTE1YmQ2NGI0ZTRlZTJhMzE0MF8yMzM5_b4416efc-f8c6-419d-8aa4-a3836e9cb06f">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)&#160;</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGV4dHJlZ2lvbjphZmM5MjZhMmY5MDM0NTE1YmQ2NGI0ZTRlZTJhMzE0MF8yMzQ0_38767d2d-39db-4315-90ac-c70355639586">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGV4dHJlZ2lvbjphZmM5MjZhMmY5MDM0NTE1YmQ2NGI0ZTRlZTJhMzE0MF8yMzQw_dc60df8e-11b5-4aa5-a56f-bad6c9800769">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-bottom:10pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"></td><td style="width:40.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.763%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGFibGU6ZGYzNmM1YzZmMjgyNDcwZDhhOWIzOWZkNjg0MDQzNzEvdGFibGVyYW5nZTpkZjM2YzVjNmYyODI0NzBkOGE5YjM5ZmQ2ODQwNDM3MV8xLTAtMS0xLTA_49500bc3-201c-4d80-823b-30c55b48bbca">Common Stock, Par Value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGFibGU6ZGYzNmM1YzZmMjgyNDcwZDhhOWIzOWZkNjg0MDQzNzEvdGFibGVyYW5nZTpkZjM2YzVjNmYyODI0NzBkOGE5YjM5ZmQ2ODQwNDM3MV8xLTEtMS0xLTA_0a9cf370-089a-45a7-bc5c-442ff46b685d">EBS</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGFibGU6ZGYzNmM1YzZmMjgyNDcwZDhhOWIzOWZkNjg0MDQzNzEvdGFibGVyYW5nZTpkZjM2YzVjNmYyODI0NzBkOGE5YjM5ZmQ2ODQwNDM3MV8xLTItMS0xLTA_c2f5a59e-0fb9-4ea8-bc08-13e5f386fcd0">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:10pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in&#160;Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if3aafa3d443e41a792eadbfdef9d62f4_D20210520-20210520" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmZjMDg3YWI2OTliMTQ1OTNiM2VlM2M2NjNhMGU2NDBhL3NlYzpmYzA4N2FiNjk5YjE0NTkzYjNlZTNjNjYzYTBlNjQwYV8xL2ZyYWc6YWZjOTI2YTJmOTAzNDUxNWJkNjRiNGU0ZWUyYTMxNDAvdGV4dHJlZ2lvbjphZmM5MjZhMmY5MDM0NTE1YmQ2NGI0ZTRlZTJhMzE0MF8yMzQx_7043c2ee-5ce3-4583-88e0-b4c8911c2e4b">&#9744;</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 5.02  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Amendment to Stock Incentive Plan</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:39.6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 20, 2021, Emergent BioSolutions Inc. (the &#8220;Company&#8221;) held its 2021 annual meeting of stockholders (the &#8220;Annual Meeting&#8221;).  At the Annual Meeting, the Company&#8217;s stockholders approved the Emergent BioSolutions Inc. Amended and Restated Stock Incentive Plan (the &#8220;Amended Plan&#8221;).  The Board of Directors previously adopted the Amended Plan on March 18, 2021, subject to stockholder approval.      </span></div><div style="text-align:justify;text-indent:39.6pt"><span><br/></span></div><div style="text-align:justify;text-indent:39.6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Amended Plan increases the number of shares of the Company&#8217;s common stock available for issuance under the plan by 3,500,000 shares, subject to adjustment in the event of stock splits and other similar events and removes references to Section 162(m) of the Internal Revenue Code of 1986, as amended.</span></div><div style="text-align:justify;text-indent:39.6pt"><span><br/></span></div><div style="text-align:justify;text-indent:39.6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The description above is a summary of certain provisions contained in the Amended Plan and does not purport to be complete.  A more fulsome description of the terms and conditions of the Amended Plan is set forth in the Company&#8217;s definitive proxy statement on Schedule 14A related to the Annual Meeting, filed on April 9, 2021 (the &#8220;Proxy Statement&#8221;).  Such descriptions are qualified in their entirety by reference to the Amended Plan, a blacklined copy of which is attached as Appendix A to the Proxy Statement.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Departure of Director</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:39.6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dr. Sue Bailey completed her term as a director of the Company and did not stand for reelection when her term as a Class III director expired at the Annual Meeting.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 5.07  Submission of Matters to a Vote of Security Holders</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:39.6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As noted above, the Annual Meeting was held on May 20, 2021. A total of 49,582,397 shares of the Company&#8217;s common stock were present or represented by proxy, which represented approximately 92.54% of the Company&#8217;s 53,576,925 shares of common stock that were outstanding and entitled to vote at the Annual Meeting as of the record date of March 25, 2021.  Stockholders considered the four proposals outlined below, each of which is described in more detail in the Proxy Statement.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:39.6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Proposal 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  To elect three Class III directors to hold office for a term expiring at our 2024 annual meeting of stockholders and until their respective successors are duly elected and qualified.  All director nominees were elected.  The voting results were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Director Nominee</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">For</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Against</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Abstaining</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Robert Kramer</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">46,009,428</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,220,174</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">115,345</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,237,450</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Jerome Hauer</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">43,425,265</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3,804,300</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">115,382</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,237,450</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Marvin White</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">38,135,285</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8,490,961</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">718,701</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,237,450</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Proposal 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  To ratify the appointment by the Audit Committee of Ernst &amp; Young LLP as our Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2021.  Proposal 2 was approved.  The voting results were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">For</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Against</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Abstaining</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">49,001,106</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">538,419</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">42,872</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">N/A</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Proposal 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  To approve, on an advisory basis, the compensation of our named executive officers.  Proposal 3 was approved.  The voting results were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">For</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Against</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Abstaining</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">45,345,745</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,957,145</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">42,057</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,237,450</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Proposal 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.  To approve an amendment to our stock incentive plan.  Proposal 4 was approved.  The voting results were as follows:</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">For</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Against</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Abstaining</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">44,092,331</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3,208,764</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">43,852</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,237,450</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 7.01  Regulation FD Disclosure.</span></div><div><span><br/></span></div><div style="text-indent:39.6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 20, 2021, Company management delivered a presentation at the Annual Meeting. A copy of the presentation is being furnished as Exhibit 99 hereto.</span></div><div style="text-indent:39.6pt"><span><br/></span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.  Financial Statements and Exhibits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:3pt;margin-top:3pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (d)</span><span style="color:#000000;font-family:'Franklin Gothic Book',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits.</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.935%"><tr><td style="width:1.0%"></td><td style="width:14.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.276%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.090%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit&#160;No.&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ebsvasm2021-visualscover.htm">Annual Meeting Presentation.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Emergent BioSolutions Inc. Current Report on Form 8-K, dated May 20, 2021, formatted in XBRL (Extensible Business Reporting Language): Cover Page. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:50.182%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.971%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EMERGENT BIOSOLUTIONS INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: May 25, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ RICHARD S. LINDAHL</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:  Richard S. Lindahl<br/>Title:  Executive Vice President, Chief Financial<br/>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Officer and Treasurer</span></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:10pt"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "ebs-20210520.htm", "description": "8-K", "secsgml_size_bytes": 57396}]
{"company-data": {"conformed-name": "Emergent BioSolutions Inc.", "cik": "0001367644", "assigned-sic": "2834", "irs-number": "141902018", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-33137", "film-number": "21961468"}, "business-address": {"street1": "400 PROFESSIONAL DR, SUITE 400", "city": "GAITHERSBURG", "state": "MD", "zip": "20879", "phone": "240-631-3200"}, "mail-address": {"street1": "400 PROFESSIONAL DR, SUITE 400", "city": "GAITHERSBURG", "state": "MD", "zip": "20879"}}
ebs-20210520
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 20, 2021
EMERGENT BIOSOLUTIONS INC.
(Exact name of registrant as specified in its charter)
Delaware
001-33137
14-1902018
(State or other jurisdiction
(Commission File Number)
(IRS Employer
of incorporation)
Identification No.)
400 Professional Drive
,
Suite 400
,
Gaithersburg
,
Maryland
20879
(Address of principal executive offices, including zip code)
(
240
)
631-3200
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, Par Value $0.001 per share
EBS
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 5.02  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
.
Amendment to Stock Incentive Plan
On May 20, 2021, Emergent BioSolutions Inc. (the "Company") held its 2021 annual meeting of stockholders (the "Annual Meeting").  At the Annual Meeting, the Company's stockholders approved the Emergent BioSolutions Inc. Amended and Restated Stock Incentive Plan (the "Amended Plan").  The Board of Directors previously adopted the Amended Plan on March 18, 2021, subject to stockholder approval.
The Amended Plan increases the number of shares of the Company's common stock available for issuance under the plan by 3,500,000 shares, subject to adjustment in the event of stock splits and other similar events and removes references to Section 162(m) of the Internal Revenue Code of 1986, as amended.
The description above is a summary of certain provisions contained in the Amended Plan and does not purport to be complete.  A more fulsome description of the terms and conditions of the Amended Plan is set forth in the Company's definitive proxy statement on Schedule 14A related to the Annual Meeting, filed on April 9, 2021 (the "Proxy Statement").  Such descriptions are qualified in their entirety by reference to the Amended Plan, a blacklined copy of which is attached as Appendix A to the Proxy Statement.
Departure of Director
Dr. Sue Bailey completed her term as a director of the Company and did not stand for reelection when her term as a Class III director expired at the Annual Meeting.
Item 5.07  Submission of Matters to a Vote of Security Holders
.
As noted above, the Annual Meeting was held on May 20, 2021. A total of 49,582,397 shares of the Company's common stock were present or represented by proxy, which represented approximately 92.54% of the Company's 53,576,925 shares of common stock that were outstanding and entitled to vote at the Annual Meeting as of the record date of March 25, 2021.  Stockholders considered the four proposals outlined below, each of which is described in more detail in the Proxy Statement.
Proposal 1
.  To elect three Class III directors to hold office for a term expiring at our 2024 annual meeting of stockholders and until their respective successors are duly elected and qualified.  All director nominees were elected.  The voting results were as follows:
Director Nominee
For
Against
Abstaining
Broker Non-Votes
Robert Kramer
46,009,428
1,220,174
115,345
2,237,450
Jerome Hauer
43,425,265
3,804,300
115,382
2,237,450
Marvin White
38,135,285
8,490,961
718,701
2,237,450
Proposal 2
.  To ratify the appointment by the Audit Committee of Ernst & Young LLP as our Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2021.  Proposal 2 was approved.  The voting results were as follows:
For
Against
Abstaining
Broker Non-Votes
49,001,106
538,419
42,872
N/A
Proposal 3
.  To approve, on an advisory basis, the compensation of our named executive officers.  Proposal 3 was approved.  The voting results were as follows:
For
Against
Abstaining
Broker Non-Votes
45,345,745
1,957,145
42,057
2,237,450
Proposal 4
.  To approve an amendment to our stock incentive plan.  Proposal 4 was approved.  The voting results were as follows:
For
Against
Abstaining
Broker Non-Votes
44,092,331
3,208,764
43,852
2,237,450
Item 7.01  Regulation FD Disclosure.
On May 20, 2021, Company management delivered a presentation at the Annual Meeting. A copy of the presentation is being furnished as Exhibit 99 hereto.
Item 9.01.  Financial Statements and Exhibits
.
(d)
Exhibits.
Exhibit No.
Description
99
Annual Meeting Presentation.
101
Emergent BioSolutions Inc. Current Report on Form 8-K, dated May 20, 2021, formatted in XBRL (Extensible Business Reporting Language): Cover Page. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
104
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
EMERGENT BIOSOLUTIONS INC.
Dated: May 25, 2021
By:
/s/ RICHARD S. LINDAHL
Name:  Richard S. Lindahl
Title:  Executive Vice President, Chief Financial
Officer and Treasurer